EUVIMEDEUVIMED entdecken
Leitlinie

China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement

Qiang Yu

Journal of European Competition Law & Practice · 31.07.2026

DOI: 10.1093/jeclap/lpag047 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of European Competition Law & Practice, online erschienen am 31.07.2026. Verfasst von Qiang Yu.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yu, Q. (2026). China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement. Journal of European Competition Law & Practice. https://doi.org/10.1093/jeclap/lpag047

Vancouver

Yu Q. China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement. Journal of European Competition Law & Practice. 2026. doi:10.1093/jeclap/lpag047

BibTeX
@article{Yu2026,
  author = {Yu, Qiang},
  title = {China’s guidelines for antitrust in the pharmaceutical sector: publication and enforcement},
  journal = {Journal of European Competition Law & Practice},
  year = {2026},
  doi = {10.1093/jeclap/lpag047}
}
Kostenlos starten →